Nick Chng

407 total citations
19 papers, 186 citations indexed

About

Nick Chng is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nick Chng has authored 19 papers receiving a total of 186 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Radiation and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nick Chng's work include Advanced Radiotherapy Techniques (10 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Advanced X-ray and CT Imaging (5 papers). Nick Chng is often cited by papers focused on Advanced Radiotherapy Techniques (10 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Advanced X-ray and CT Imaging (5 papers). Nick Chng collaborates with scholars based in Canada, United States and Belgium. Nick Chng's co-authors include Ingrid Spadinger, William Morris, Septimiu E. Salcudean, S. Sara Mahdavi, Nawaid Usmani, Robert Olson, Quinn Matthews, Mitchell Liu, Benjamin Mou and Mira Keyes and has published in prestigious journals such as The Lancet Oncology, International Journal of Radiation Oncology*Biology*Physics and Medical Physics.

In The Last Decade

Nick Chng

16 papers receiving 182 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nick Chng Canada 9 101 74 60 49 42 19 186
Gaetano Villa Italy 8 68 0.7× 72 1.0× 19 0.3× 64 1.3× 131 3.1× 9 291
P. Meershoek Netherlands 8 143 1.4× 53 0.7× 16 0.3× 73 1.5× 100 2.4× 15 285
James I. Monroe United States 9 128 1.3× 194 2.6× 36 0.6× 77 1.6× 180 4.3× 23 321
K. Gnep France 10 238 2.4× 98 1.3× 23 0.4× 53 1.1× 194 4.6× 24 368
Sébastien Clippe France 9 111 1.1× 135 1.8× 38 0.6× 32 0.7× 123 2.9× 23 272
Kaya Doyeux France 7 98 1.0× 61 0.8× 24 0.4× 24 0.5× 236 5.6× 14 288
M. La Macchia Italy 7 147 1.5× 156 2.1× 17 0.3× 57 1.2× 117 2.8× 9 340
Thorsten Frenzel Germany 10 167 1.7× 144 1.9× 59 1.0× 68 1.4× 245 5.8× 22 363
Xinzhi Teng Hong Kong 12 98 1.0× 78 1.1× 39 0.7× 76 1.6× 281 6.7× 41 356
Haibo Lin United States 7 238 2.4× 196 2.6× 23 0.4× 21 0.4× 99 2.4× 20 295

Countries citing papers authored by Nick Chng

Since Specialization
Citations

This map shows the geographic impact of Nick Chng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Chng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Chng more than expected).

Fields of papers citing papers by Nick Chng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Chng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Chng. The network helps show where Nick Chng may publish in the future.

Co-authorship network of co-authors of Nick Chng

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Chng. A scholar is included among the top collaborators of Nick Chng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Chng. Nick Chng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Chng, Nick, et al.. (2024). 92 Clinical Implementation of a Novel Re-Irradiation Treatment Planning Workflow. Radiotherapy and Oncology. 198. S42–S42.
3.
Baker, Sarah, Benjamin Mou, C. Lund, et al.. (2022). Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 Trial. International Journal of Radiation Oncology*Biology*Physics. 114(4). 617–626. 21 indexed citations
4.
Baker, Sarah, Benjamin Mou, Alanah Bergman, et al.. (2022). Predictors of Early Polymetastatic Relapse After SABR for up to 5 Oligometastases: A Secondary Analysis of the Phase II SABR-5 Trial. International Journal of Radiation Oncology*Biology*Physics. 114(5). 856–861. 3 indexed citations
5.
Bergman, Alanah, Wilko F.A.R. Verbakel, Lucy Ward, et al.. (2022). Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 114(5). 1016–1021. 15 indexed citations
7.
Kucharczyk, Michael Jonathan, Joshua Giambattista, Carter Kolbeck, et al.. (2022). 18: A Randomized Blinded Assessment of a Machine Learning Based Autocontouring Tool for Breast Cancer Radiotherapy Compared to Peer-Reviewed Radiation Oncologist Contours. Radiotherapy and Oncology. 174. S11–S11.
8.
9.
Olson, Robert, Mitchell Liu, Alanah Bergman, et al.. (2018). Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5. BMC Cancer. 18(1). 954–954. 10 indexed citations
10.
Spadinger, Ingrid, et al.. (2016). Source strength verification and quality assurance of preloaded brachytherapy needles using a CMOS flat panel detector. Medical Physics. 43(6Part1). 3008–3018. 1 indexed citations
11.
Keyes, Mira, William Morris, Ingrid Spadinger, et al.. (2012). Radiation oncology and medical physicists quality assurance in British Columbia Cancer Agency Provincial Prostate Brachytherapy Program. Brachytherapy. 12(4). 343–355. 25 indexed citations
12.
Lobo, Julio, Mehdi Moradi, Nick Chng, et al.. (2011). Quantifying Stranded Implant Displacement Following Prostate Brachytherapy. Lecture notes in computer science. 14(Pt 1). 307–314. 1 indexed citations
13.
Mahdavi, S. Sara, Ingrid Spadinger, Nick Chng, Septimiu E. Salcudean, & William Morris. (2011). Semiautomatic segmentation for prostate brachytherapy: Dosimetric evaluation. Brachytherapy. 12(1). 65–76. 10 indexed citations
14.
Mahdavi, S. Sara, Nick Chng, Ingrid Spadinger, William Morris, & Septimiu E. Salcudean. (2010). Semi-automatic segmentation for prostate interventions. Medical Image Analysis. 15(2). 226–237. 55 indexed citations
15.
Usmani, Nawaid, Nick Chng, Ingrid Spadinger, & William Morris. (2010). Lack of significant intraprostatic migration of stranded iodine-125 sources in prostate brachytherapy implants. Brachytherapy. 10(4). 275–285. 17 indexed citations
16.
Spadinger, Ingrid, William Morris, Mira Keyes, Mitchell Liu, & Nick Chng. (2010). Regional Extraprostatic Dose Metrics as Predictors of Biochemical Relapse in 125I Prostate Brachytherapy. Brachytherapy. 9. S42–S42. 1 indexed citations
17.
Usmani, Nawaid, Nick Chng, Ingrid Spadinger, & William Morris. (2010). Lack of Migration of 125I RapidStrands® in Prostate Brachytherapy Implants. Brachytherapy. 9. S75–S76. 2 indexed citations
18.
Morris, William, et al.. (2009). 3D Prostate Segmentation in Ultrasound Images Based on Tapered and Deformed Ellipsoids. Lecture notes in computer science. 12(Pt 2). 960–967. 10 indexed citations
19.
Spadinger, Ingrid, William Morris, Mira Keyes, et al.. (2009). Quadrant dosimetry as a predictor of biochemical relapse in 125I prostate brachytherapy. Brachytherapy. 8(2). 126–126. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026